Liliana Ascione

Milan, 20122, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

A Mitochondrial Plasma Proteomic Signature Identifies Metastatic Chromophobe Renal Cell Carcinoma.

A Mitochondrial Plasma Proteomic Signature Identifies Metastatic Chromophobe Renal Cell Carcinoma.

Journal: Cancers

Published: February 08, 2026

KIM-1 and Circulating Tumor DNA Are Prognostic Markers for Oligometastatic Clear-cell Renal Cell Carcinoma: Development of a Multivariable Prognostic Model.

KIM-1 and Circulating Tumor DNA Are Prognostic Markers for Oligometastatic Clear-cell Renal Cell Carcinoma: Development of a Multivariable Prognostic Model.

Journal: European urology

Published: September 12, 2025

Integrative Clinical and Molecular Evaluation of Renal Cell Carcinoma with Merlin Protein Deficiency and Biallelic Loss of NF2.

Integrative Clinical and Molecular Evaluation of Renal Cell Carcinoma with Merlin Protein Deficiency and Biallelic Loss of NF2.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 31, 2025

The Safety and Suitability of DNA Sequencing of Tissue Biopsies Performed on Patients Referred to a Phase I Unit.

The Safety and Suitability of DNA Sequencing of Tissue Biopsies Performed on Patients Referred to a Phase I Unit.

Journal: Cancers

Published: October 10, 2024

Endocrine therapy for early breast cancer in the era of oral selective estrogen receptor degraders: challenges and future perspectives.

Endocrine therapy for early breast cancer in the era of oral selective estrogen receptor degraders: challenges and future perspectives.

Journal: Current opinion in oncology

Published: September 09, 2024

Innovative payloads for ADCs in cancer treatment: moving beyond the selective delivery of chemotherapy.

Innovative payloads for ADCs in cancer treatment: moving beyond the selective delivery of chemotherapy.

Journal: Therapeutic advances in medical oncology

Published: July 16, 2024

Unlocking the Potential: Biomarkers of Response to Antibody-Drug Conjugates.

Unlocking the Potential: Biomarkers of Response to Antibody-Drug Conjugates.

Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

Published: June 03, 2024

Deleterious alterations in homologous recombination repair genes and efficacy of platinum-based chemotherapy in biliary tract cancers.

Deleterious alterations in homologous recombination repair genes and efficacy of platinum-based chemotherapy in biliary tract cancers.

Journal: The oncologist

Published: January 09, 2024

Screening Programs for Breast Cancer: Toward Individualized, Risk-Adapted Strategies of Early Detection.

Screening Programs for Breast Cancer: Toward Individualized, Risk-Adapted Strategies of Early Detection.

Journal: Cancer treatment and research

Published: January 04, 2024

Cancers of Unknown Primary Origin: Real-World Clinical Outcomes and Genomic Analysis at the European Institute of Oncology.

Cancers of Unknown Primary Origin: Real-World Clinical Outcomes and Genomic Analysis at the European Institute of Oncology.

Journal: The oncologist

Published: December 19, 2023

Use of Antibody-Drug Conjugates in the Early Setting of Breast Cancer.

Use of Antibody-Drug Conjugates in the Early Setting of Breast Cancer.

Journal: Clinical Medicine Insights. Oncology

Published: December 01, 2023

Circulating tumor DNA in patients with locally advanced rectal cancer treated with multimodal treatment.

Circulating tumor DNA in patients with locally advanced rectal cancer treated with multimodal treatment.

Journal: Therapeutic advances in medical oncology

Published: October 16, 2023

Showing 1-12 of 28

Last Updated: 09/26/2026